Asset Dedication LLC’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,587
Closed -$155K 837
2019
Q3
$155K Buy
1,587
+617
+64% +$58.6K 0.05% 185
2019
Q2
$88K Buy
970
+493
+103% +$46.8K 0.03% 233
2019
Q1
$44K Buy
477
+125
+36% +$10.9K 0.02% 286
2018
Q4
$20K Sell
352
-62
-15% -$4.58K 0.01% 363
2018
Q3
$37K Sell
414
-98
-19% -$8.66K 0.01% 289
2018
Q2
$44K Sell
512
-340
-40% -$28.2K 0.02% 283
2018
Q1
$75K Sell
852
-96
-10% -$9.22K 0.04% 200
2017
Q4
$98K Sell
948
-116
-11% -$13.1K 0.04% 182
2017
Q3
$149K Hold
1,064
0.07% 142
2017
Q2
$138K Hold
1,064
0.07% 151
2017
Q1
$136K Hold
1,064
0.07% 146
2016
Q4
$131K Sell
1,064
-141
-12% -$15.7K 0.08% 150
2016
Q3
$126K Buy
1,205
+145
+14% +$15.7K 0.08% 142
2016
Q2
$102K Sell
1,060
-54
-5% -$5.59K 0.07% 145
2016
Q1
$112K Sell
1,114
-54
-5% -$5.56K 0.08% 137
2015
Q4
$140K Buy
+1,168
New +$135K 0.09% 159

Other funds holding CELG

Asset Dedication LLC's CELG Position: Q4 2019 in Review

Asset Dedication LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,587 shares — an estimated $155K sold.

Asset Dedication LLC first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $155K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Asset Dedication LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Asset Dedication LLC sold 1,587 Celgene Corp shares in Q4 2019, an estimated $155K.
  • Asset Dedication LLC first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Asset Dedication LLC's Celgene Corp position peaked at $155K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Asset Dedication LLC's 13F filing for Q4 2019, filed 31 Jan 2020.